Diabetes drug combo safe for type 2 patients with CKD

Newer drugs deliver kidney and cardiovascular protection, says renal expert
Clare Pain
Diabetes drugs

Adding two classes of diabetes medications to the drug regimens of patients with type 2 diabetes and chronic kidney disease can reduce both blood glucose levels and albuminuria, a study shows.

The findings come from a double-blind placebo-controlled trial that investigated the effects of dapagliflozin (10mg/day) and saxagliptin (2.5mg/day) on patients who were also taking their usual diabetes medications and an angiotensin-converting enzyme inhibitor or an angiotensin II receptor inhibitor.